Balance Sheet Dive: Aehr Test Systems (AEHR)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

After finishing at $9.64 in the prior trading day, Aehr Test Systems (NASDAQ: AEHR) closed at $8.85, down -8.20%. In other words, the price has decreased by -$8.20 from its previous closing price. On the day, 1.11 million shares were traded.

Ratios:

Our goal is to gain a better understanding of AEHR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 7.55. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on July 17, 2024, Upgraded its rating to Buy and sets its target price to $25 from $12 previously.

On March 26, 2024, Craig Hallum Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 02 ’24 when SLAYEN HOWARD T bought 20,000 shares for $15.50 per share. The transaction valued at 310,000 led to the insider holds 220,714 shares of the business.

DANESH FARIBA bought 10,000 shares of AEHR for $185,800 on Jul 30 ’24. On Jul 30 ’24, another insider, DANESH FARIBA, who serves as the Director of the company, sold 10,000 shares for $18.59 each. As a result, the insider received 185,900 and left with 16,390 shares of the company.

Valuation Measures:

As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.85, and their Forward P/E ratio for the next fiscal year is 22.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.18 while its Price-to-Book (P/B) ratio in mrq is 2.13.

Stock Price History:

Over the past 52 weeks, AEHR has reached a high of $21.44, while it has fallen to a 52-week low of $9.30. The 50-Day Moving Average of the stock is -30.69%, while the 200-Day Moving Average is calculated to be -33.06%.

Shares Statistics:

A total of 29.71M shares are outstanding, with a floating share count of 27.83M. Insiders hold about 6.32% of the company’s shares, while institutions hold 70.80% stake in the company.

Earnings Estimates

Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is $0.14, with high estimates of $0.16 and low estimates of $0.12.

Analysts are recommending an EPS of between $0.33 and $0.23 for the fiscal current year, implying an average EPS of $0.28. EPS for the following year is $0.4, with 2.0 analysts recommending between $0.45 and $0.35.

Revenue Estimates

2 analysts predict $17.76M in revenue for the current quarter. It ranges from a high estimate of $17.89M to a low estimate of $17.63M. As of the current estimate, Aehr Test Systems’s year-ago sales were $7.56MFor the next quarter, 2 analysts are estimating revenue of $24.37M. There is a high estimate of $25.94M for the next quarter, whereas the lowest estimate is $22.8M.

A total of 2 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $70.41M, while the lowest revenue estimate was $67M, resulting in an average revenue estimate of $68.71M. In the same quarter a year ago, actual revenue was $66.22MBased on 2 analysts’ estimates, the company’s revenue will be $84.75M in the next fiscal year. The high estimate is $85.02M and the low estimate is $84.49M.

Most Popular